Fumitaka Mizoguchi

4.1k citations
60 papers · 1.2k indexed · h-index 17
Topics
Antibiotics Pharmacokinetics and Efficacy (12 papers)Inflammatory Myopathies and Dermatomyositis (8 papers)Rheumatoid Arthritis Research and Therapies (7 papers)

In The Last Decade

Fumitaka Mizoguchi

56 papers receiving 1.2k citations

Peers

Fumitaka Mizoguchi
Comparison fields: 5 of 91
  • Molecular Biology 577
  • Cancer Research 237
  • Immunology 223
  • Rheumatology 208
  • Oncology 201
Replace Zhenbiao Wu with:
Zhenbiao Wu China
Meiying Qi United States
Eri Katsuyama Japan
Szandor Simmons Germany
Sarah Howat United Kingdom
Hannes Olauson Sweden
Jeong-Hee Yang South Korea
Katherine Staines United Kingdom
Kyungho Choi South Korea
P.W.M. Ho Australia
Fumitaka Mizoguchi relative to Zhenbiao Wu China Zhenbiao Wu's profile →
Citations per field
00.5×3.6×
Zhenbiao Wu · 1×
Citations per year

Countries citing papers authored by Fumitaka Mizoguchi

Since Specialization
Citations

This map shows the geographic impact of Fumitaka Mizoguchi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fumitaka Mizoguchi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fumitaka Mizoguchi more than expected).

Fields of papers citing papers by Fumitaka Mizoguchi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fumitaka Mizoguchi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fumitaka Mizoguchi. The network helps show where Fumitaka Mizoguchi may publish in the future.

Co-authorship network of co-authors of Fumitaka Mizoguchi

This figure shows the co-authorship network connecting the top 25 collaborators of Fumitaka Mizoguchi. A scholar is included among the top collaborators of Fumitaka Mizoguchi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fumitaka Mizoguchi. Fumitaka Mizoguchi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 2
3 49
4 11
5 56
6 14
7 27
8 131
9 11
10 13
11 45
12 7
13
[Control of bone remodeling by nervous system. Nervous system and bone].
2
14 4
15 14
16 108
17 4
18 25
19 21
20
[Pharmacological evaluation of an ampicillin suppository (KS-R1) in acute pneumonia in children--a comparison with a parenteral preparation of ampicillin].
1

About Fumitaka Mizoguchi

Fumitaka Mizoguchi is a scholar working on Rheumatology, Pharmacology and Genetics, having authored 60 papers that have together received 1.2k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (12 papers), Inflammatory Myopathies and Dermatomyositis (8 papers) and Rheumatoid Arthritis Research and Therapies (7 papers). The work is most often cited by research in Cancer Research (237 citations), Sensory Systems (74 citations) and Rheumatology (208 citations). Fumitaka Mizoguchi has collaborated with scholars based in Japan, United States and Australia. Frequent co-authors include Nobuyuki Miyasaka, Hitoshi Kohsaka, Tadayoshi Hayata, Yoichi Ezura, Masaki Noda, Kazuhisa Nakashima, Tetsuya Saito, Yousuke Murakami, Michael B. Brenner and Erika H. Noss. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026